Hemosphere is a commercial medical device company specialized in vascular access for patients on dialysis.
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 7, 2010 | Series A | $9.30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cutlass Capital | — | Series A |